Camurus AB (publ) (LON:0RD1)
642.10
+17.28 (2.77%)
At close: Jul 4, 2025
Camurus AB Employees
Camurus AB had 256 employees as of December 31, 2024. The number of employees increased by 43 or 20.19% compared to the previous year.
Employees
256
Change (1Y)
43
Growth (1Y)
20.19%
Revenue / Employee
592.40K GBP
Profits / Employee
159.39K GBP
Market Cap
2.94B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Camurus AB News
- 18 days ago - Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients - PRNewsWire
- 4 weeks ago - Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins - PRNewsWire
- 2 months ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 9 months ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 1 year ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire